FilingReader Intelligence

Jinyu Bio-Tech subsidiary gains new veterinary drug certificate

April 3, 2025 at 05:00 AM UTCBy FilingReader AI

Jinyu Bio-Technology Co., Ltd. (SSE:600201) announced that its subsidiary, Jinyu Baoling Biological Drugs Co., Ltd., in collaboration with its holding subsidiary, Liaoning Yikang Biological Co., Ltd., has received a new veterinary drug registration certificate for its inactivated vaccine against Clostridium perfringens type A (CNM0708 strain) in cattle. The vaccine, categorized as a Class II new veterinary drug, is designed to prevent bovine sudden death syndrome caused by Clostridium perfringens type A.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600201Shanghai Stock Exchange
Animal Health

News Alerts

Get instant email alerts when Jinyu Bio-Technology publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →